Exodus Point Capital Management, LP Sesen Bio, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.49 - $0.61 $21,462 - $26,718	43,800 New	43,800 $27,000
Q4 2021 Feb 11, 2022	SELL	$0.73 - $1.28 $42,581 - $74,663	-58,331 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$0.77 - $4.91 $44,914 - $286,405	58,331 New	58,331 $46,000
Q2 2021 Aug 16, 2021	SELL	$2.18 - $4.66 $571,554 - $1.22 Million	-262,181 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.3 - $3.24 $290,785 - $724,726	223,681 Added 580.99%	262,181 $682,000
Q4 2020 Feb 16, 2021	BUY	$1.01 - $1.77 $38,885 - $68,145	38,500 New	38,500 $52,000
Q1 2020 May 15, 2020	SELL	$0.39 - $1.03 $54,626 - $144,269	-140,067 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.89 - $1.5 $124,659 - $210,100	140,067 New	140,067 $146,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.